{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T04:39:39Z","timestamp":1791607179165,"version":"4.3.4"},"reference-count":34,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2021,2,11]],"date-time":"2021-02-11T00:00:00Z","timestamp":1613001600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>Diazoxide is the first-line drug for treating hyperinsulinism and the only pharmacological agent approved for hyperinsulinism by the Federal Drug Administration. This systemic review and meta-analysis aimed to investigate the efficacy and safety of diazoxide for treating hyperinsulinemic hypoglycemia (HH). The meta-analysis of the efficacy and safety of diazoxide in treating HH was performed by searching relevant studies in the PubMed, Embase, and Cochrane databases. The findings were summarized, and the pooled effect size and its 95% confidence interval (CI) were calculated. A total of 6 cohort studies, involving 1142 participants, met the inclusion criteria. Among the cohort studies, the pooled estimate of the response rate of diazoxide therapy was 71% (95% CI 50%\u201393%, <jats:italic>P<\/jats:italic><jats:sub>heterogeneity<\/jats:sub>&lt; 0.001, <jats:italic>I<\/jats:italic><jats:sup><jats:italic>2<\/jats:italic><\/jats:sup> = 98.3%, <jats:italic>P<\/jats:italic><jats:sub>effect<\/jats:sub>&lt; 0.001). The common side effects were hypertrichosis (45%), fluid retention (20%), gastrointestinal reaction (13%), edema (11%), and neutropenia (9%). Other adverse events included pulmonary hypertension (2%) and thrombocytopenia (2%). This meta-analysis suggested that diazoxide was potentially useful in HH management; however, it had some side effects, which needed careful monitoring. Furthermore, well-designed large-scale studies, such as randomized controlled trials, might be necessary in the future to obtain more evidence.<\/jats:p>","DOI":"10.1371\/journal.pone.0246463","type":"journal-article","created":{"date-parts":[[2021,2,11]],"date-time":"2021-02-11T23:28:15Z","timestamp":1613086095000},"page":"e0246463","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":43,"title":["Efficacy and safety of diazoxide for treating hyperinsulinemic hypoglycemia: A systematic review and meta-analysis"],"prefix":"10.1371","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2351-7611","authenticated-orcid":true,"given":"Xiaohong","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lifang","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luhong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2021,2,11]]},"reference":[{"key":"pone.0246463.ref001","first-page":"1472","article-title":"Diagnosis and therapeutic guideline of hyperinsulinemic hypoglycemia","volume":"110","author":"T Hasegawa","year":"2006","journal-title":"J Japan Pediatr Soc"},{"issue":"4","key":"pone.0246463.ref002","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/ped.12390","article-title":"Congenital hyperinsulinism: Global and J apanese perspectives","volume":"56","author":"T Yorifuji","year":"2014","journal-title":"Pediatrics International"},{"key":"pone.0246463.ref003","volume-title":"Seminars in pediatric surgery","author":"SE Flanagan","year":"2011"},{"issue":"8","key":"pone.0246463.ref004","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1681\/ASN.2016121312","article-title":"Polycystic kidney disease with hyperinsulinemic hypoglycemia caused by a promoter mutation in phosphomannomutase 2","volume":"28","author":"OR Cabezas","year":"2017","journal-title":"Journal of the American Society of Nephrology"},{"issue":"6","key":"pone.0246463.ref005","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1056\/NEJMoa1206605","article-title":"Multiple phenotypes in phosphoglucomutase 1 deficiency","volume":"370","author":"LC Tegtmeyer","year":"2014","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"pone.0246463.ref006","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1159\/000351943","article-title":"Dominant form of congenital hyperinsulinism maps to HK1 region on 10q","volume":"80","author":"SE Pinney","year":"2013","journal-title":"Horm Res Paediatr"},{"issue":"12","key":"pone.0246463.ref007","doi-asserted-by":"crossref","first-page":"3785","DOI":"10.1210\/jc.2010-3032","article-title":"Morphological mosaicism of the pancreatic islets: a novel anatomopathological form of persistent hyperinsulinemic hypoglycemia of infancy","volume":"96","author":"C Sempoux","year":"2011","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"issue":"Suppl 2","key":"pone.0246463.ref008","first-page":"69","article-title":"Congenital Hyperinsulinism: Diagnosis and Treatment Update","volume":"9","author":"H Demirbilek","year":"2017","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"pone.0246463.ref009","first-page":"1","article-title":"Current and Emerging Agents for the Treatment of Hypoglycemia in Patients with Congenital Hyperinsulinism","author":"AP De Cosio","year":"2019","journal-title":"Pediatric Drugs"},{"issue":"2","key":"pone.0246463.ref010","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1749-6632.1968.tb19059.x","article-title":"The therapeutic application of diazoxide in pediatric hypoglycemic states","volume":"150","author":"A Drash","year":"1968","journal-title":"Annals of the New York Academy of Sciences"},{"key":"pone.0246463.ref011","author":"J von Oettingen","year":"2019","journal-title":"Application for inclusion of Diazoxide in the WHO Model List of Essential Medicines for Children"},{"issue":"4","key":"pone.0246463.ref012","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2174\/092986706775527947","article-title":"Towards selective Kir6. 2\/SUR1 potassium channel openers, medicinal chemistry and therapeutic perspectives","volume":"13","author":"JB Hansen","year":"2006","journal-title":"Current medicinal chemistry"},{"issue":"1","key":"pone.0246463.ref013","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1530\/eje.0.1490043","article-title":"Long-term follow-up of 114 patients with congenital hyperinsulinism","volume":"149","author":"T Meissner","year":"2003","journal-title":"European journal of endocrinology"},{"issue":"11\u201312","key":"pone.0246463.ref014","first-page":"1119","article-title":"The treatment effect of diazoxide on 44 patients with congenital hyperinsulinism","volume":"25","author":"S Hu","year":"2012","journal-title":"Journal of Pediatric Endocrinology and Metabolism"},{"issue":"3","key":"pone.0246463.ref015","doi-asserted-by":"crossref","first-page":"194","DOI":"10.4274\/jcrpe.3934","article-title":"Congenital hyperinsulinism in China: a review of Chinese literature over the past 15 years","volume":"9","author":"W-Y Wang","year":"2017","journal-title":"Journal of clinical research in pediatric endocrinology"},{"issue":"3","key":"pone.0246463.ref016","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1297\/cpe.27.131","article-title":"Safety and effectiveness, including intelligence prognosis, of diazoxide in pediatric patients with hyperinsulinemic hypoglycemia: special survey in Japan (long-term, all-case survey)","volume":"27","author":"M Fukutomi","year":"2018","journal-title":"Clinical Pediatric Endocrinology"},{"issue":"12","key":"pone.0246463.ref017","doi-asserted-by":"crossref","first-page":"4365","DOI":"10.1210\/jc.2018-01613","article-title":"Prevalence of adverse events in children with congenital hyperinsulinism treated with diazoxide","volume":"103","author":"A Herrera","year":"2018","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"issue":"1","key":"pone.0246463.ref018","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1159\/000497458","article-title":"Rate of serious adverse events associated with diazoxide treatment of patients with hyperinsulinism","volume":"91","author":"P Thornton","year":"2019","journal-title":"Hormone research in paediatrics"},{"issue":"4","key":"pone.0246463.ref019","doi-asserted-by":"crossref","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"151","author":"D Moher","year":"2009","journal-title":"Annals of internal medicine"},{"issue":"9","key":"pone.0246463.ref020","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","article-title":"Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses","volume":"25","author":"A Stang","year":"2010","journal-title":"European journal of epidemiology"},{"issue":"9","key":"pone.0246463.ref021","doi-asserted-by":"crossref","first-page":"820","DOI":"10.7326\/0003-4819-127-9-199711010-00008","article-title":"Quantitative synthesis in systematic reviews","volume":"127","author":"J Lau","year":"1997","journal-title":"Annals of internal medicine"},{"issue":"Suppl 1","key":"pone.0246463.ref022","doi-asserted-by":"crossref","first-page":"e000858","DOI":"10.1136\/bmjgh-2018-000858","article-title":"Synthesising quantitative evidence in systematic reviews of complex health interventions","volume":"4","author":"JPT Higgins","year":"2019","journal-title":"BMJ global health"},{"issue":"7109","key":"pone.0246463.ref023","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"M Egger","year":"1997","journal-title":"Bmj"},{"issue":"2","key":"pone.0246463.ref024","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.0006-341X.2000.00455.x","article-title":"Trim and fill: a simple funnel\u2010plot\u2013based method of testing and adjusting for publication bias in meta\u2010analysis","volume":"56","author":"S Duval","year":"2000","journal-title":"Biometrics"},{"issue":"1","key":"pone.0246463.ref025","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s13023-015-0367-x","article-title":"Long-term medical treatment in congenital hyperinsulinism: a descriptive analysis in a large cohort of patients from different clinical centers","volume":"10","author":"A Welters","year":"2015","journal-title":"Orphanet journal of rare diseases"},{"issue":"6","key":"pone.0246463.ref026","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/0026-0495(64)90133-7","article-title":"Drug therapy in leucine-sensitive hypoglycemia","volume":"13","author":"A Drash","year":"1964","journal-title":"Metabolism-Clinical and Experimental"},{"issue":"8","key":"pone.0246463.ref027","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1177\/003591576505800805","article-title":"Hyperinsulinism due to metastasizing insulinoma: treatment with diazoxide","volume":"58","author":"V Marks","year":"1965","journal-title":"Proceedings of the Royal Society of Medicine"},{"issue":"864","key":"pone.0246463.ref028","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1136\/pgmj.73.864.640","article-title":"Diazoxide treatment for insulinoma: a national UK survey","volume":"73","author":"G Gill","year":"1997","journal-title":"Postgraduate medical journal"},{"issue":"10","key":"pone.0246463.ref029","article-title":"In vitro insulin secretion by pancreatic tissue from infants with diazoxide-resistant congenital hyperinsulinism deviates from model predictions","volume":"121","author":"J-C Henquin","year":"2011","journal-title":"The Journal of clinical investigation"},{"issue":"5","key":"pone.0246463.ref030","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1530\/EJE-10-1136","article-title":"The contribution of rapid KATP channel gene mutation analysis to the clinical management of children with congenital hyperinsulinism","volume":"164","author":"I Banerjee","year":"2011","journal-title":"European journal of endocrinology"},{"issue":"1","key":"pone.0246463.ref031","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/ncpendmet0368","article-title":"Mechanisms of disease: advances in diagnosis and treatment of hyperinsulinism in neonates","volume":"3","author":"DD De Le\u00f3n","year":"2007","journal-title":"Nature Reviews Endocrinology"},{"issue":"6","key":"pone.0246463.ref032","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1096\/fj.07-099424","article-title":"Human hair follicles contain two forms of ATP-sensitive potassium channels, only one of which is sensitive to minoxidil","volume":"22","author":"K Shorter","year":"2008","journal-title":"The FASEB Journal"},{"key":"pone.0246463.ref033","author":"U Food","year":"2015","journal-title":"FDA warns about a serious lung condition in infants and newborns treated with Proglycem (diazoxide)"},{"issue":"11","key":"pone.0246463.ref034","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1038\/s41372-018-0218-4","article-title":"Prevalence and safety of diazoxide in the neonatal intensive care unit","volume":"38","author":"KD Gray","year":"2018","journal-title":"Journal of Perinatology"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0246463","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,11]],"date-time":"2021-02-11T23:28:40Z","timestamp":1613086120000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0246463"}},"subtitle":[],"editor":[{"given":"Cho","family":"Naing","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,2,11]]},"references-count":34,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,2,11]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0246463","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,11]]}}}